Class 2 Medicines Recall: Depo-medrone 80 Mg In 2 Ml, Maxearn Limited El(25)a/29
Depo-Medrone Recall Summary A batch of Depo-Medrone 80 mg injectable medication sold in the United Kingdom has incorrect labeling on the vial—the label says it contains 40 mg in 1 mL when it actually contains 80 mg in 2 mL. This labeling error could lead to dosing mistakes if healthcare providers or patients rely on the incorrect information. The recall affects vials distributed by Maxearn Limited with batch number EL(25)A/29.
- Recalling firm
- Depo-Medrone 80 mg in 2 mL
- Reason
- A batch of Depo-Medrone has been released to the market with an error. The vial over label incorrectly states that the total vial content is 40 mg in 1 mL, when the correct total vial content is 80mg in 2 mL (with a concentration of 40mg/ml of methylprednisolone acetate).
- Classification
- Class II
- Category
- drug recall
- Country
- United Kingdom
- Agency
- UK Medicines and Healthcare products Regulatory Agency
- Recall date
- 2025-06-25
- Status
- Ongoing
- Distribution
- United Kingdom
Official recall notice from UK Medicines and Healthcare products Regulatory Agency
Recall details on Nibble Recalls: https://trynibble.app/recalls/1e4e93e5-462e-4571-8945-3a7731abc005